Affiliation:
1. Department of Pathology, Virginia Commonwealth University , Richmond, VA 23298-06629 , USA
2. Department of Pathology, Medical College of Wisconsin , Milwaukee, WI 53226 , USA
Abstract
Abstract
The pathogenesis of breast cancer is driven by multiple hormones and growth factors. One of these, prolactin (PRL), contributes to both mammary differentiation and oncogenesis, and yet the basis for these disparate effects has remained unclear. The focus of this review is to examine and place into context 2 recent studies that have provided insight into the roles of PRL receptors and PRL in tumorigenesis and tumor progression. One study provides novel evidence for opposing actions of PRL in the breast being mediated in part by differential PRL receptor (PRLr) isoform utilization. Briefly, homomeric complexes of the long isoform of the PRLr (PRLrL-PRLrL) promotes mammary differentiation, while heteromeric complexes of the intermediate and long PRLr (PRLrI-PRLrL) isoforms trigger mammary oncogenesis. Another study describes an immunodeficient, prolactin-humanized mouse model, NSG-Pro, that facilitates growth of PRL receptor-expressing patient-derived breast cancer xenografts. Evidence obtained with this model supports the interactions of physiological levels of PRL with estrogen and ERBB2 gene networks, the modulatory effects of PRL on drug responsiveness, and the pro-metastatic effects of PRL on breast cancer. This recent progress provides novel concepts, mechanisms and experimental models expected to renew interest in harnessing/exploiting PRLr signaling for therapeutic effects in breast cancer.
Reference120 articles.
1. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice;Osborne;Cancer Res.,1985
2. Breast cancer, stem cells and sex hormones. Part 2: the impact of the reproductive years and pregnancy;Eden;Maturitas.,2010
3. Systemic adjuvant therapy in the treatment of primary operable breast cancer: National surgical adjuvant breast and bowel project experiment;Fischer;NCI Monogr.,1986
4. Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice;Rose-Hellekant;Oncogene.,2003
5. Interaction of Estrogen and Prolactin in Spontaneous Mammary Tumorgenesis of the Mouse;Welsch;J Toxicol Environ Health.,1976
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献